A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a) | stella

Learn Data Labs For Researchers Find trials matched to me

Learn Data Labs For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a) | stella

Back to Adult Participants With Elevated Lipoprotein(a) trials

Opening soon

Plain-English translation of NCT07640217 on ClinicalTrials.gov ↗ · Source last updated June 2026 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Key details

Phase

Testing effectiveness

Sponsor

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Enrollment target

~120 participants

Started

July 2026

Primary completion

March 2028

Age range

18 Years and older

Last updated on clinicaltrials.gov in June 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Clinical Trials Information Group officer

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.